Indian Rivaroxaban Exporters: Complete Supplier Ranking with Market Share — 497 Manufacturers (2026) — TransData Nexus

Q: Who is the largest rivaroxaban buyer importing from India?

MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS) is the largest rivaroxaban importer from India with a 25.2% market share and import value of $13.3M.

Q: How many rivaroxaban buyers import from India?

There are 497 active rivaroxaban buyers importing from India, with a combined import market of $52.6M across 5,361 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top rivaroxaban buyers from India?

The top 5 rivaroxaban buyers — MYLAN IRELAND C/O ALLOGA RDC,, PHARMADOX HEALTHCARE LTD, TO THE PURCHASE MANAGER, APOTEX INC, PHARMADOX HEALTHCARE LIMITED — together control 42.3% of total rivaroxaban import value from India.

Suresh Sormare

Rivaroxaban

India Pharmaceutical Trade Intelligence

$52.6M221 Suppliers115 CountriesHS 30049099

ExportsIndia → NETHERLANDS29.9%India → MALTA9.6%

ImportsGERMANY → India$34.1B CANADA → India$46.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Market Analysis: Top Importing Countries & Their Importers

1Netherlands

Netherlands emerges as the first largest importing country, achieving a total trade value of $15.7M through 162 shipments. This represents a market share of 29.9% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Netherlands has a diverse importer base, with their top importers including:

• MYLAN IRELAND C/O ALLOGA RDC, - $13.3M (84.3% of country's total business)

• MYLAN IRELAND C/O ALLOGA RDC,. - $911.1K (5.8% of country's total business)

• MYLAN IRELAND - $653.5K (4.2% of country's total business)

Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $97.0K, indicating premium pricing strategy compared to the market average of $9.8K.

Netherlands is a key market for Rivaroxaban imports, representing 29.9% of total trade value.

Primary Market

Secondary Market

2Malta

Malta emerges as the second largest importing country, achieving a total trade value of through . This represents a market share of of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Rivaroxaban buyer market intelligence

1Buyer Segment Analysis

The 497 buyers of Rivaroxaban from India can be categorized into several segments:

1. Distributors: Entities like MYLAN IRELAND C/O ALLOGA RDC (Netherlands, $13.25M) and APOTEX INC (Canada, $1.27M) fall into this category. These companies purchase large volumes to supply pharmacies, hospitals, and other healthcare providers. Their buying behavior typically involves regular, high-volume orders to maintain a steady supply chain.

2. Contract Manufacturers: Companies such as PHARMADOX HEALTHCARE LTD (Malta, $3.93M) and GMP MANUFACTURING LTD (United Kingdom, $0.71M) are contract manufacturers. They procure Rivaroxaban to produce finished pharmaceutical products for other brands or companies. Their purchasing patterns are project-based, aligning with production schedules and client demands.

3. Government Procurement Agencies: Entities like HEALTH CARE AGENCY, SEYCHELLES (Seychelles, $0.92M) represent government procurement. These agencies acquire medications for public healthcare systems, often through tender-based processes. Their orders are typically large and periodic, corresponding with budget cycles and public health needs.

4. Re-exporters: Companies such as DEPO PACK SNC (Italy, $0.86M) may act as re-exporters, purchasing Rivaroxaban to supply other markets. Their buying behavior is influenced by global demand fluctuations and trade agreements.

5. Hospital Groups and Retail Chains: While not explicitly listed among the top buyers, hospital groups and retail chains also procure Rivaroxaban directly for patient care. Their orders are generally smaller and more frequent, based on immediate patient needs and inventory management practices.

Country-Specific Import Regulations

TransData Nexus Rivaroxaban buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Rivaroxaban are as follows:

1. Netherlands:

Drug Regulatory Authority: Medicines Evaluation Board (MEB).

Import Registration Process: Importers must obtain a marketing authorization from the MEB, which involves submitting a dossier demonstrating the product's quality, safety, and efficacy.

Estimated Timeline for Registration: Approximately 210 days, subject to the completeness of the application.

Import Tariff/Duty for HS 30049099: As an EU member, the Netherlands applies a 0% import duty on pharmaceutical products under this HS code.

2. Malta:

Drug Regulatory Authority: Malta Medicines Authority (MMA).

Import Registration Process: Requires a marketing authorization from the MMA, including submission of product information and compliance with EU directives.

Demand Drivers & Market Opportunity

TransData Nexus Rivaroxaban buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Rivaroxaban in importing countries is driven by several factors:

1. Disease Prevalence: Rivaroxaban is primarily used to prevent and treat thromboembolic disorders. The prevalence of conditions such as atrial fibrillation and deep vein thrombosis has been increasing globally, contributing to higher demand for anticoagulant therapies.

2. Government Healthcare Programs: Many countries have implemented programs to improve access to essential medicines. For instance, the WHO's Model List of Essential Medicines includes anticoagulants like Rivaroxaban, encouraging member states to prioritize their procurement.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased public funding for essential medicines, including anticoagulants, thereby boosting demand.

4. Tender-Based Purchasing: Government and international organizations often procure medicines through tenders, ensuring large-scale purchases and stable demand. The inclusion of Rivaroxaban in such tenders reflects its recognized therapeutic value.

With 497 buyers across 115 countries, the market for Rivaroxaban imported from India demonstrates significant global reach and sustained demand, presenting ongoing opportunities for exporters.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Rivaroxaban Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest rivaroxaban buyer importing from India?

Based on import volume and value, MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS) leads with $13.3M in imports and a 25.2% market share — the highest of any single rivaroxaban importer. PHARMADOX HEALTHCARE LTD (MALTA) and TO THE PURCHASE MANAGER (ECUADOR) are the next largest buyers.

QHow many companies buy rivaroxaban from India?

There are 497 active rivaroxaban buyers importing from India, with a combined market of $52.6M across 5,361 shipments to 115 countries. The top 5 buyers hold 42.3% of total import value, while the remaining 492 buyers handle the other 57.7%.

QWhich countries import the most rivaroxaban from India?

The top importing countries for rivaroxaban from India are Netherlands (29.9%), Malta (9.6%), Ecuador (6.2%), Canada (6.0%), Brazil (5.0%). These markets represent the largest demand centres for Indian pharmaceutical exports of rivaroxaban, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for rivaroxaban from India?

The average import transaction value for rivaroxaban from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Rivaroxaban buyer market intelligence

1Buyer Segment Analysis

The 497 buyers of Rivaroxaban from India can be categorized into several segments:

Country-Specific Import Regulations

TransData Nexus Rivaroxaban buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Rivaroxaban are as follows:

1. Netherlands:

Drug Regulatory Authority: Medicines Evaluation Board (MEB).

Import Registration Process: Importers must obtain a marketing authorization from the MEB, which involves submitting a dossier demonstrating the product's quality, safety, and efficacy.

Estimated Timeline for Registration: Approximately 210 days, subject to the completeness of the application.

Import Tariff/Duty for HS 30049099: As an EU member, the Netherlands applies a 0% import duty on pharmaceutical products under this HS code.

2. Malta:

Drug Regulatory Authority: Malta Medicines Authority (MMA).

Import Registration Process: Requires a marketing authorization from the MMA, including submission of product information and compliance with EU directives.

Demand Drivers & Market Opportunity

TransData Nexus Rivaroxaban buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Rivaroxaban in importing countries is driven by several factors:

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased public funding for essential medicines, including anticoagulants, thereby boosting demand.

With 497 buyers across 115 countries, the market for Rivaroxaban imported from India demonstrates significant global reach and sustained demand, presenting ongoing opportunities for exporters.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rivaroxaban

Rivaroxaban

Who Buys Rivaroxaban from India — 497 Importers Behind a $52.6M Market

Top Rivaroxaban Importers — Ranked by Import Value

Top Rivaroxaban Buyers & Importers

Related Analysis

Need Details?

Rivaroxaban — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Rivaroxaban — and from which countries?

Rivaroxaban — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Netherlands

2Malta

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Rivaroxaban Buyers & Importers

QWho is the largest rivaroxaban buyer importing from India?

QHow many companies buy rivaroxaban from India?

QWhich countries import the most rivaroxaban from India?

QWhat is the average import order value for rivaroxaban from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Ecuador

4Canada

5Brazil

Analysis Methodology